Lista de obras - Claudio Vernieri - Dominio Público Uruguay

Adaptation to the spindle checkpoint is regulated by the interplay between Cdc28/Clbs and PP2ACdc55

artículo científico publicado en 2013

Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study.

artículo científico publicado en 2017

Cells Escape an Operational Mitotic Checkpoint through a Stochastic Process

artículo científico publicado en 2017

Cellular response upon proliferation in the presence of an active mitotic checkpoint

scientific article published on 08 May 2019

Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies

artículo científico publicado en 2019

DHA Affects Microtubule Dynamics Through Reduction of Phospho-TCTP Levels and Enhances the Antiproliferative Effect of T-DM1 in Trastuzumab-Resistant HER2-Positive Breast Cancer Cell Lines

scientific article published on 19 May 2020

Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectives.

artículo científico publicado en 2018

Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

artículo científico publicado en 2020

Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer

artículo científico publicado en 2017

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential

artículo científico publicado en 2017

Evidence that Aurora B is implicated in spindle checkpoint signalling independently of error correction ⬇️

artículo científico publicado en 2011

Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial

scientific article published on 19 December 2018

Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape

artículo científico publicado en 2021

Fasting-mimicking diet plus chemotherapy in breast cancer treatment

scientific article published on 26 August 2020

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer.

artículo científico

Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications

artículo científico publicado en 2020

Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients

artículo científico publicado en 2021

How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies

artículo científico publicado en 2016

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

scientific article published on 03 January 2019

Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)

scientific article published on 07 January 2019

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting

artículo científico publicado en 2018

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer

artículo científico publicado en 2018

LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial

artículo científico publicado en 2020

Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence

scientific article published on 04 May 2020

Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC

scientific article published on 24 August 2018

Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes

artículo científico publicado en 2016

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors

artículo científico publicado en 2019

Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study

artículo científico publicado en 2020

Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment

artículo científico publicado en 2019

Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up.

artículo científico publicado en 2016

Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors

artículo científico

Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives

artículo científico publicado en 2019

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

article

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles

scientific article published on 12 December 2018

Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions

artículo científico publicado en 2016

The AURORA of a New Way to Value Myeloid Immunosuppression in Cancer

scientific article published on 01 July 2019

The PAR complex controls the spatiotemporal dynamics of F-actin and the MTOC in directionally migrating leukocytes

artículo científico publicado en 2014

Update on medical treatment of small intestinal neuroendocrine tumors

artículo científico publicado en 2016

Lista de obras de Claudio Vernieri

Adaptation to the spindle checkpoint is regulated by the interplay between Cdc28/Clbs and PP2ACdc55

Antitumor activity and safety profile of weekly carboplatin plus paclitaxel in metastatic breast cancer: a ten-year, monocentric, retrospective study.

Cells Escape an Operational Mitotic Checkpoint through a Stochastic Process

Cellular response upon proliferation in the presence of an active mitotic checkpoint

Combination of Baseline LDH, Performance Status and Age as Integrated Algorithm to Identify Solid Tumor Patients with Higher Probability of Response to Anti PD-1 and PD-L1 Monoclonal Antibodies

DHA Affects Microtubule Dynamics Through Reduction of Phospho-TCTP Levels and Enhances the Antiproliferative Effect of T-DM1 in Trastuzumab-Resistant HER2-Positive Breast Cancer Cell Lines

Diet and supplements in cancer prevention and treatment: Clinical evidences and future perspectives.

Early Changes of the Standardized Uptake Values (SUVmax) Predict the Efficacy of Everolimus-Exemestane in Patients with Hormone Receptor-Positive Metastatic Breast Cancer

Emergence of MET hyper-amplification at progression to MET and BRAF inhibition in colorectal cancer

Everolimus treatment for neuroendocrine tumors: latest results and clinical potential

Evidence that Aurora B is implicated in spindle checkpoint signalling independently of error correction ⬇️

Exploiting FAsting-mimicking Diet and MEtformin to Improve the Efficacy of Platinum-pemetrexed Chemotherapy in Advanced LKB1-inactivated Lung Adenocarcinoma: The FAME Trial

Fasting-mimicking diet blocks triple-negative breast cancer and cancer stem cell escape

Fasting-mimicking diet plus chemotherapy in breast cancer treatment

Heterogeneity of Acquired Resistance to Anti-EGFR Monoclonal Antibodies in Patients with Metastatic Colorectal Cancer.

Hormone Receptor Loss in Breast Cancer: Molecular Mechanisms, Clinical Settings, and Therapeutic Implications

Hormone receptor status influences the impact of body mass index and hyperglycemia on the risk of tumor relapse in early-stage HER2-positive breast cancer patients

How do the results of the RADIANT trials impact on the management of NET patients? A systematic review of published studies

Impact of Metformin Use and Diabetic Status During Adjuvant Fluoropyrimidine-Oxaliplatin Chemotherapy on the Outcome of Patients with Resected Colon Cancer: A TOSCA Study Subanalysis

Impact of systemic and tumor lipid metabolism on everolimus efficacy in advanced pancreatic neuroendocrine tumors (pNETs)

Innovative therapy, monoclonal antibodies, and beyond: Highlights from the eighth annual meeting

Intratumor lactate levels reflect HER2 addiction status in HER2-positive breast cancer

LKB1 mutations are not associated with the efficacy of first-line and second-line chemotherapy in patients with advanced non-small-cell lung cancer (NSCLC): a post hoc analysis of the TAILOR trial

Metabolism and Immune Modulation in Patients with Solid Tumors: Systematic Review of Preclinical and Clinical Evidence

Metformin Enhances Cisplatin-Induced Apoptosis and Prevents Resistance to Cisplatin in Co-mutated KRAS/LKB1 NSCLC

Metformin with everolimus and octreotide in pancreatic neuroendocrine tumor patients with diabetes

Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors

Morphological Factors Related to Nodal Metastases in Neuroendocrine Tumors of the Appendix: A Multicentric Retrospective Study

Phenethyl isothiocyanate hampers growth and progression of HER2-positive breast and ovarian carcinoma by targeting their stem cell compartment

Primary Cerebellar Neuroendocrine Tumors: Chimeras or Real Entities? A Case Report with a 6-Year Follow-Up.

Rationale and protocol of MetNET-2 trial: Lanreotide Autogel plus metformin in advanced gastrointestinal or lung neuroendocrine tumors

Resistance mechanisms to anti-HER2 therapies in HER2-positive breast cancer: Current knowledge, new research directions and therapeutic perspectives

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

Single-Agent Gemcitabine vs. Carboplatin-Gemcitabine in Advanced Breast Cancer: A Retrospective Comparison of Efficacy and Safety Profiles

Targeting Cancer Metabolism: Dietary and Pharmacologic Interventions

The AURORA of a New Way to Value Myeloid Immunosuppression in Cancer

The PAR complex controls the spatiotemporal dynamics of F-actin and the MTOC in directionally migrating leukocytes

Update on medical treatment of small intestinal neuroendocrine tumors